Crystal structure of 6,6a,7,8,9,10-hexahydro-5H-pyrazino [2,3-e]pyrido[1,2-a]pyrazine, C10H14N4-Reference-Cited by-同舟云学术

Crystal structure of 6,6a,7,8,9,10-hexahydro-5H-pyrazino [2,3-e]pyrido[1,2-a]pyrazine, C₁₀H₁₄N₄

Published:2023-09-05 Issue:6 Volume:238 Page:1137-1139
ISSN:1433-7266
Container-title:Zeitschrift für Kristallographie - New Crystal Structures
language:en
Short-container-title:

Author:

Dali Zhu¹^ORCID,Yu Yu¹

Affiliation:

1. School of Pharmacy, Chongqing Medical University , Chongqing 400016 , P.R. China

Abstract

Abstract C10H14N4, orthorhombic, Pbca (no. 61), a = 15.5356(2) Å, b = 9.8551(2) Å, c = 25.5551(4) Å, V = 3912.61(11) Å3, Z = 16, R gt (F) = 0.0873, wR ref (F 2) = 0.2481, T = 150 K.

Publisher

Walter de Gruyter GmbH

Subject

Inorganic Chemistry,Condensed Matter Physics,General Materials Science

Link

https://www.degruyter.com/document/doi/10.1515/ncrs-2023-0363/pdf

Reference9 articles.

1. Agilent Technologies. CrysAlisPro Version 1.171.37.35; Agilent Technologies UK Ltd: Yarnton: England, 2014.

2. Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K., Puschmann, H. OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 2009, 42, 339–341; https://doi.org/10.1107/s0021889808042726.

3. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.

4. Farrugia, L. J. WinGX and ORTEP for Windows: an update. J. Appl. Crystallogr. 2012, 45, 849–854; https://doi.org/10.1107/s0021889812029111.

5. Gan, L. L., Gan, Z. J., Dan, Y. R., Li, Y. W., Zhang, P. M., Chen, S. W., Ye, Z. J., Pan, T., Wan, C. M., Hu, X. L., Yu, Y. Tetrazanbigen derivatives as peroxisome proliferator-activated receptor gamma (PPARγ) partial agonists: design, synthesis, structure-activity relationship, and anticancer activities. J. Med. Chem. 2021, 64, 1018–1036; https://doi.org/10.1021/acs.jmedchem.0c01512.